Literature DB >> 31098744

Evaluating the structural complexity of isomeric bile acids with ion mobility spectrometry.

Xueyun Zheng1, Francesca B Smith2, Noor A Aly3, Jingwei Cai4, Richard D Smith2, Andrew D Patterson4, Erin S Baker5,6.   

Abstract

Bile acids (BAs) play an integral role in digestion through the absorption of nutrients, emulsification of fats and fat-soluble vitamins, and maintenance of cholesterol levels. Metabolic disruption, diabetes, colorectal cancer, and numerous other diseases have been linked with BA disruption, making improved BA analyses essential. To date, most BA measurements are performed using liquid chromatography separations in conjunction with mass spectrometry measurements (LC-MS). However, 10-40 min LC gradients are often used for BA analyses and these may not even be sufficient for distinguishing all the important isomers present in the human body. Ion mobility spectrometry (IMS) is a promising tool for BA evaluations due to its ability to quickly separate isomeric molecules with subtle structural differences. In this study, we utilized drift tube IMS (DTIMS) coupled with MS to characterize 56 different unlabeled BA standards and 16 deuterated versions. In the DTIMS-MS analyses of 12 isomer groups, BAs with smaller m/z values were easily separated in either their deprotonated or sodiated forms (or both). However, as the BAs grew in m/z value, they became more difficult to separate with two isomer groups being inseparable. Metal ions such as copper and zinc were then added to the overlapping BAs, and due to different binding sites, the resulting complexes were separable. Thus, the rapid structural measurements possible with DTIMS-MS show great potential for BAs measurements with and without prior LC separations.

Entities:  

Keywords:  Bile acids; Collisional cross sections; Ion mobility spectrometry

Mesh:

Substances:

Year:  2019        PMID: 31098744      PMCID: PMC6612315          DOI: 10.1007/s00216-019-01869-0

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  28 in total

1.  Bile acid profiling in human biological samples: comparison of extraction procedures and application to normal and cholestatic patients.

Authors:  Lydie Humbert; Marie Anne Maubert; Claude Wolf; Henri Duboc; Myriam Mahé; Dominique Farabos; Philippe Seksik; Jean Maurice Mallet; Germain Trugnan; Joëlle Masliah; Dominique Rainteau
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-05-17       Impact factor: 3.205

Review 2.  The continuing importance of bile acids in liver and intestinal disease.

Authors:  A F Hofmann
Journal:  Arch Intern Med       Date:  1999 Dec 13-27

3.  Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Ines Burkard; Arnold von Eckardstein; Katharina M Rentsch
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-09-22       Impact factor: 3.205

4.  Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus.

Authors:  Katerina Dvorak; Claire M Payne; Melissa Chavarria; Lois Ramsey; Barbora Dvorakova; Harris Bernstein; Hana Holubec; Richard E Sampliner; Naihsuan Guy; Amanda Condon; Carol Bernstein; Sylvan B Green; Anil Prasad; Harinder S Garewal
Journal:  Gut       Date:  2006-12-04       Impact factor: 23.059

5.  Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method.

Authors:  Juan C García-Cañaveras; M Teresa Donato; José V Castell; Agustín Lahoz
Journal:  J Lipid Res       Date:  2012-07-19       Impact factor: 5.922

6.  Quantification of the 15 major human bile acids and their precursor 7α-hydroxy-4-cholesten-3-one in serum by liquid chromatography-tandem mass spectrometry.

Authors:  Carine Steiner; Arnold von Eckardstein; Katharina M Rentsch
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-09-09       Impact factor: 3.205

7.  Bile reflux gastritis and intestinal metaplasia at the cardia.

Authors:  M F Dixon; N P Mapstone; P M Neville; P Moayyedi; A T R Axon
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

8.  Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease.

Authors:  Carsten Gnewuch; Gerhard Liebisch; Thomas Langmann; Benjamin Dieplinger; Thomas Mueller; Meinhard Haltmayer; Hans Dieplinger; Alexandra Zahn; Wolfgang Stremmel; Gerhard Rogler; Gerd Schmitz
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

9.  Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry.

Authors:  Max Scherer; Carsten Gnewuch; Gerd Schmitz; Gerhard Liebisch
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-10-02       Impact factor: 3.205

10.  Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen?

Authors:  R K Ross; N M Hartnett; L Bernstein; B E Henderson
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

View more
  3 in total

1.  Recent Advances in Understanding of Alzheimer's Disease Progression through Mass Spectrometry-Based Metabolomics.

Authors:  Jericha Mill; Lingjun Li
Journal:  Phenomics       Date:  2022-02-22

2.  Rapid and Simultaneous Characterization of Drug Conjugation in Heavy and Light Chains of a Monoclonal Antibody Revealed by High-Resolution Ion Mobility Separations in SLIM.

Authors:  Gabe Nagy; Isaac K Attah; Christopher R Conant; Weijing Liu; Sandilya V B Garimella; Harsha P Gunawardena; Jared B Shaw; Richard D Smith; Yehia M Ibrahim
Journal:  Anal Chem       Date:  2020-03-17       Impact factor: 6.986

3.  Collision Cross Section Conformational Analyses of Bile Acids via Ion Mobility-Mass Spectrometry.

Authors:  James C Poland; Katrina L Leaptrot; Stacy D Sherrod; Charles Robb Flynn; John A McLean
Journal:  J Am Soc Mass Spectrom       Date:  2020-06-29       Impact factor: 3.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.